Immune checkpoint blockade therapy for bladder cancer treatment
Bladder cancer remains the most immunogenic and expensive malignant tumor in the United States today. As the 4th leading cause of death from cancer in United States, Immunotherapy blocking immune checkpoints have been recently been applied to many aggressive cancers and changed interventions of ur...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Urological Association
2016-06-01
|
| Series: | Investigative and Clinical Urology |
| Subjects: | |
| Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-S98.pdf |